Teske Noelle M, Jacobe Heidi T
Department of Dermatology, University of Texas at Southwestern Medical Center, Dallas, TX.
Department of Dermatology, University of Texas at Southwestern Medical Center, Dallas, TX.
Clin Dermatol. 2016 Sep-Oct;34(5):614-22. doi: 10.1016/j.clindermatol.2016.05.012. Epub 2016 May 20.
Phototherapy is an effective treatment strategy for a variety of sclerosing skin conditions. There are a number of phototherapeutic modalities used for the treatment of sclerosing skin conditions, including ultraviolet (UV)A1, broadband UVA, psoralen plus UVA, and narrowband UVB phototherapy. As controlled trials with validated outcome measures are lacking for these therapies, existing evidence is largely level II for morphea and is even more minimal for scleroderma and other sclerosing disorders (scleroderma, lichen sclerosus, and chronic graft-versus-host disease, among others). Studies do suggest that phototherapy may be effective for many of these disorders, including those that have been unresponsive to other therapies. Phototherapy remains an attractive therapeutic option for patients due to its efficacy and favorable risk-versus-benefit profile. Phototherapy also offers a therapeutic alternative to systemic immunosuppressives for patients who cannot tolerate these medications.
光疗是治疗多种硬化性皮肤病的有效治疗策略。有多种光疗方式用于治疗硬化性皮肤病,包括紫外线(UV)A1、宽带UVA、补骨脂素加UVA以及窄带UVB光疗。由于缺乏针对这些疗法的具有验证结局指标的对照试验,现有证据对于硬斑病大多为二级证据,而对于系统性硬化症和其他硬化性疾病(如系统性硬化症、硬化性苔藓和慢性移植物抗宿主病等)则更为有限。研究确实表明,光疗可能对许多这些疾病有效,包括那些对其他疗法无反应的疾病。由于其疗效和良好的风险效益比,光疗对患者来说仍然是一个有吸引力的治疗选择。对于无法耐受全身性免疫抑制剂的患者,光疗也提供了一种治疗替代方案。